Linezolid-Induced Lactic Acidosis in Tuberculosis: A Systematic Review of Published Case Reports and Case Series
The Journal of Association of Chest Physicians · 2026-01 · 14 (1) · 8-14
DOI: 10.4103/jacp.jacp_45_25 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Association of Chest Physicians, online erschienen am 24.04.2026. Verfasst von Rajiv Garg und 6 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Linezolid is widely used in the treatment of drug-resistant tuberculosis (TB), despite being associated with severe adverse effects, including lactic acidosis, which remains underreported in the literature and is fatal in many cases. This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered in PROSPERO (CRD42024552225). We conducted comprehensive searches across PubMed, Scopus, Embase, and Google Scholar, covering case reports and case series without language restrictions. Data were extracted on demographics, clinical presentation, linezolid dosage, laboratory findings, treatment regimens, and outcomes. Lactic acidosis was defined as a serum pH 4 mmol/L. Quality assessment followed the protocol of Murad et al . Data were synthesized narratively and statistically analyzed using Microsoft Excel. Seven case reports were identified. The average patient age was 49.33 years (range: 20–81 years), with a near-equal distribution between males and females. Most cases were reported from India (3/7). Respiratory symptoms predominated, and gastrointestinal and central nervous system involvement was also noted. Linezolid dosing varied between 600 and 1200 mg daily. Arterial blood gas analysis showed significant acidosis, with pH values ranging from 6.09 to 7.32. Lactate levels were elevated (range: 10.2–20 mmol/L). Symptoms emerged from within 7 days to over 1 month after starting linezolid, except for one patient who developed symptoms immediately. Four patients died, and three survived after treatment modification. Linezolid-induced lactic acidosis is a rare but serious complication in drug-resistant TB, emphasizing the need for close monitoring and individualized treatment.
Zitieren
APA
Garg, R., Garg, R. K., Garg, P., Srivastava, A., Bajaj, D. K., Singhal, S., & Ahuja, K. (2026). Linezolid-Induced Lactic Acidosis in Tuberculosis: A Systematic Review of Published Case Reports and Case Series. The Journal of Association of Chest Physicians, 14(1), 8-14. https://doi.org/10.4103/jacp.jacp_45_25
Vancouver
Garg R, Garg RK, Garg P, Srivastava A, Bajaj DK, Singhal S, et al. Linezolid-Induced Lactic Acidosis in Tuberculosis: A Systematic Review of Published Case Reports and Case Series. The Journal of Association of Chest Physicians. 2026;14(1):8-14. doi:10.4103/jacp.jacp_45_25
BibTeX
@article{Garg2026,
author = {Garg, Rajiv and Garg, Ravindra Kumar and Garg, Pragati and Srivastava, Anand and Bajaj, Darshan Kumar and Singhal, Sanjay and Ahuja, Kriti},
title = {Linezolid-Induced Lactic Acidosis in Tuberculosis: A Systematic Review of Published Case Reports and Case Series},
journal = {The Journal of Association of Chest Physicians},
year = {2026},
volume = {14},
number = {1},
pages = {8--14},
doi = {10.4103/jacp.jacp_45_25}
}
EUVIMED